CIBC Asset Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$89.7M Buy
1,146,973
+21,631
+2% +$1.74M 0.2% 94
2026
Q1
$97.5M Buy
1,125,342
+52,412
+5% +$5.02M 0.24% 80
2025
Q4
$103M Buy
1,072,930
+166,085
+18% +$16.1M 0.25% 71
2025
Q3
$86.4M Sell
906,845
-61,347
-6% -$5.64M 0.25% 66
2025
Q2
$84.4M Sell
968,192
-8,378
-0.9% -$711K 0.26% 69
2025
Q1
$87.8M Buy
976,570
+49,331
+5% +$4.41M 0.29% 65
2024
Q4
$74.1M Buy
927,239
+14,502
+2% +$1.26M 0.24% 75
2024
Q3
$82.2M Buy
912,737
+21,662
+2% +$1.82M 0.27% 68
2024
Q2
$70.1M Sell
891,075
-28,295
-3% -$2.32M 0.25% 72
2024
Q1
$80.1M Buy
919,370
+16,589
+2% +$1.42M 0.28% 70
2023
Q4
$74.4M Sell
902,781
-25,742
-3% -$1.96M 0.28% 65
2023
Q3
$72.8M Buy
928,523
+61,141
+7% +$5.12M 0.3% 65
2023
Q2
$76.4M Sell
867,382
-43,715
-5% -$3.76M 0.29% 67
2023
Q1
$73.5M Sell
911,097
-12,671
-1% -$1.03M 0.29% 68
2022
Q4
$71.8M Sell
923,768
-371,102
-29% -$30.1M 0.3% 64
2022
Q3
$105M Buy
1,294,870
+443,658
+52% +$39.9M 0.46% 45
2022
Q2
$76.4M Buy
851,212
+44,559
+6% +$4.51M 0.31% 56
2022
Q1
$89.5M Buy
806,653
+54,816
+7% +$5.79M 0.31% 54
2021
Q4
$77.8M Buy
751,837
+276,812
+58% +$32.1M 0.28% 59
2021
Q3
$59.5M Sell
475,025
-1,134
-0.2% -$147K 0.24% 66
2021
Q2
$59.1M Buy
476,159
+350,463
+279% +$44M 0.24% 67
2021
Q1
$14.8M Buy
125,696
+5,630
+5% +$660K 0.06% 173
2020
Q4
$14.1M Buy
120,066
+1,189
+1% +$131K 0.07% 170
2020
Q3
$12.4M Buy
118,877
+5,007
+4% +$503K 0.06% 169
2020
Q2
$10.4M Sell
113,870
-489
-0.4% -$46.9K 0.06% 178
2020
Q1
$10.3M Sell
114,359
-2,491
-2% -$265K 0.07% 158
2019
Q4
$13.3M Sell
116,850
-5,327
-4% -$585K 0.08% 120
2019
Q3
$13.3M Buy
122,177
+828
+0.7% +$86.4K 0.08% 116
2019
Q2
$11.8M Sell
121,349
-58,257
-32% -$5.32M 0.07% 123
2019
Q1
$16.4M Buy
179,606
+43,548
+32% +$3.9M 0.1% 98
2018
Q4
$12.4M Sell
136,058
-3,685
-3% -$344K 0.09% 100
2018
Q3
$13.7M Sell
139,743
-1,420
-1% -$131K 0.09% 108
2018
Q2
$12.1M Buy
141,163
+1,189
+0.8% +$99.3K 0.08% 115
2018
Q1
$11.2M Sell
139,974
-660
-0.5% -$54.4K 0.07% 115
2017
Q4
$11.4M Buy
140,634
+46,692
+50% +$3.74M 0.07% 121
2017
Q3
$7.31M Sell
93,942
-2,544
-3% -$211K 0.05% 161
2017
Q2
$8.56M Buy
96,486
+3,231
+3% +$272K 0.06% 133
2017
Q1
$7.51M Buy
93,255
+8,674
+10% +$678K 0.05% 153
2016
Q4
$6.02M Sell
84,581
-36,426
-30% -$2.86M 0.04% 184
2016
Q3
$10.5M Sell
121,007
-11,126
-8% -$969K 0.08% 110
2016
Q2
$11.5M Buy
132,133
+42,925
+48% +$3.47M 0.09% 107
2016
Q1
$6.69M Hold
89,208
0.05% 150
2015
Q4
$6.86M Sell
89,208
-6,080
-6% -$458K 0.06% 145
2015
Q3
$6.38M Buy
95,288
+1,631
+2% +$120K 0.05% 155
2015
Q2
$6.94M Buy
93,657
+7,209
+8% +$551K 0.05% 161
2015
Q1
$6.74M Sell
86,448
-2,842
-3% -$215K 0.05% 160
2014
Q4
$6.45M Sell
89,290
-23,074
-21% -$1.6M 0.04% 162
2014
Q3
$6.96M Sell
112,364
-6,245
-5% -$397K 0.04% 161
2014
Q2
$7.56M Sell
118,609
-2,698
-2% -$164K 0.04% 167
2014
Q1
$7.46M Sell
121,307
-5,113
-4% -$298K 0.04% 165
2013
Q4
$7.25M Sell
126,420
-4,908
-4% -$278K 0.04% 171
2013
Q3
$6.99M Buy
131,328
+973
+0.7% +$52.4K 0.04% 167
2013
Q2
$6.71M Buy
+130,355
New +$6.44M 0.05% 162

Other funds holding MDT

CIBC Asset Management's MDT Position: Q2 2026 in Review

CIBC Asset Management increased its Medtronic (MDT) stake by 1.9% in Q2 2026, buying an estimated $1.74M and bringing the position to 1,146,973 shares worth $89.7M. The position accounts for 0.2% of the portfolio, ranked #94.

CIBC Asset Management first reported a position in MDT in Q2 2013 and has held it in 53 quarters since. The position peaked at $105M in Q3 2022. 2,123 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • CIBC Asset Management held 1,146,973 shares of Medtronic worth $89.7M as of Q2 2026.
  • CIBC Asset Management bought 21,631 Medtronic shares in Q2 2026, an estimated $1.74M.
  • Medtronic made up 0.2% of CIBC Asset Management's portfolio in Q2 2026, its #94 holding.
  • CIBC Asset Management first reported a position in Medtronic in Q2 2013 and has held it in 53 quarters since.
  • CIBC Asset Management's Medtronic position peaked at $105M in Q3 2022.
  • 2,123 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on CIBC Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.